helixir wesclab OÜ

In liquidation Registry code 17265493 OÜ Tallinn Registered 18 Jun 2025
Compare

helixir wesclab OÜ is a OÜ based in Tallinn, registry code 17265493, status: in liquidation. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q2 2026 was €0 with employees.

Turnover
0 €
↓ 100.0% vs Q1 2026
State taxes
20 €
↓ 79.2% vs Q1 2026
Labour taxes
0 €
Employees
—

Q2 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 55 566 €
    industry median 0 € · companies in the industry: 1 073
  • Net profit margin · 2025 82.8 %
    industry median 13.5 % · companies in the industry: 597

Taxes and turnover

Q3 2025 – Q2 2026
Turnover, € Q2 2026: 0 € · −100.0% vs Q1 2026 · industry median 14 545 € · above 2% of the industry
010 00020 00030 00040 000Q3 2025 Company: 12 788 € Industry median: 13 763 €Q3·25Q4 2025 Company: 32 411 € Industry median: 13 976 €Q4·25Q1 2026 Company: 21 422 € Industry median: 14 268 €Q1·26Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26010 00020 00030 00040 000Q3 2025 Company: 12 788 € Industry median: 13 763 €Q4 2025 Company: 32 411 € Industry median: 13 976 €Q4·25Q1 2026 Company: 21 422 € Industry median: 14 268 €Q2 2026 Company: 0 € Industry median: 14 545 €Q2·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

State taxes, € Q2 2026: 20 € · −79.2% vs Q1 2026
020406080100Q3 2025 Company: —Q3·25Q4 2025 Company: 0 €Q4·25Q1 2026 Company: 96 €Q1·26Q2 2026 Company: 20 €Q2·26020406080100Q3 2025 Company: —Q4 2025 Company: 0 €Q4·25Q1 2026 Company: 96 €Q2 2026 Company: 20 €Q2·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q2 2026 — 20 — —
Q1 2026 21 422 96 — —
Q4 2025 32 411 — — —
Q3 2025 12 788 — — —

Financials by year

2025 – 2025
Revenue, € 2025: 55 566 € · industry median 0 € · above 87% of the industry
020 00040 00060 0002025 Company: 55 566 € Industry median: 0 €2025020 00040 00060 0002025 Company: 55 566 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 46 015 € · industry median 0 € · above 92% of the industry
010 00020 00030 00040 00050 0002025 Company: 46 015 € Industry median: 0 €2025010 00020 00030 00040 00050 0002025 Company: 46 015 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 82.8 % · industry median 13.5 % · above 88% of the industry
0204060801002025 Company: 82.8 % Industry median: 13.5 %20250204060801002025 Company: 82.8 % Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 47 329 €
010 00020 00030 00040 00050 0002025 Company: 47 329 €2025010 00020 00030 00040 00050 0002025 Company: 47 329 €2025
Equity, € 2025: 46 316 €
010 00020 00030 00040 00050 0002025 Company: 46 316 €2025010 00020 00030 00040 00050 0002025 Company: 46 316 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.20.40.60.81.02025 Company: 0 Industry median: 120250.00.20.40.60.81.02025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 55 566 46 015 0 47 329 46 316 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
82.8 %
Net profit / revenue
Return on equity (ROE)
99.4 %
Net profit / equity
Return on assets (ROA)
97.2 %
Net profit / assets
Equity ratio
97.9 %
Equity / assets
Debt ratio
2.1 %
Liabilities / assets
Current ratio
46.72
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 18 Jun 2025 – 31 Dec 2025 3 May 2026 Company’s own e-Äriregister

Board

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main

History of changes

What Value Period
Status In liquidation 27 Oct 2026 – now
Status Active 18 Jun 2025 – now
Rulings
Number, date Title Deadline State Document
Ä 50285269 / 2
27 Oct 2026
Termination entry In force
27 Oct 2026
PDF
Ä 50285269
18 Jun 2025
First entry In force
18 Jun 2025
PDF

Sources: e-Äriregister and EMTA. Data updated 30 Oct 2026. Open at the source ↗ · Report an error in the data